Clinical Efficacy of Posterior Nasal Neurotomy in the Treatment of Allergic Rhinitis

  • Zhou Wan Department of Otolaryngology, Head and Neck Surgery, Shaanxi Provincial People's Hospital
  • Dong Lin
DOI: https://doi.org/10.18686/aem.v12i3.404
Keywords: Allergic Rhinitis; Drug Therapy; Posterior Nasal Neurotomy; Nasal Conjunctivitis Quality of Life Scale; Nasal and Sinus Outcome Test

Abstract

Objective: To analyze the clinical efficacy of posterior nasal neurotomy in the treatment of allergic rhinitis. Method: 100 patients with allergic rhinitis who received treatment at Shaanxi Provincial People's Hospital from January 2021 to January 2022 were selected as the study subjects. According to different treatment methods, patients were divided into an experimental group and a control group. There were 50 patients in each group, of which the control group was treated with drug therapy, including nasal spray of Siqing Bio rational Sea Salt Water (twice a day), nasal Fluticasone propionate nasal spray (once a day), and oral lupatadine fumarate tablets (10mg each time, once a day). The experimental group of patients underwent posterior nasal neurotomy combined with medication for treatment. After obtaining the patient's consent, track the VAS, RQLQ, and SNOT-20 scores of the patient before treatment, 3 months after treatment, and 6 months after treatment. Observe the postoperative complications in the experimental group and investigate the occurrence of adverse reactions to drugs in both groups of patients. Results: The main effect differences between VAS, RQLQ, and SNOT-20 scoring groups and time points were statistically significant (P The RQLQ and SNOT-20 scores were lower than before treatment (P<0.05). At the same time, the scores of the experimental group compared with the control group were lower than those of the control group. The experimental group will lose their sense of smell and experience complications such as atrophic rhinitis within two weeks after surgery. During drug treatment, there was no statistically significant difference in the total incidence of adverse reactions between the two groups of drugs. Conclusion: Posterior rhinotomy can alleviate clinical symptoms and further improve the quality of life of patients with allergic rhinitis. The short-term treatment effect is good, and no serious complications have occurred.

References

Yang X, Yang Y, Shan XD, et al. Observation on the efficacy of highly selective nasal nerve blockade under nasal endoscope in the treatment of moderate to severe allergic rhinitis [J]. Journal of Clinical Military Medicine, 2020 (12).

Chen P, Zheng GX. Study on the efficacy of endoscopic posterior nasal neurotomy in the treatment of moderate to severe allergic rhinitis [J]. Shaanxi Medical Journal, 2020 (11).

Liu T, Li P, Meng QX, Huang B, Xie JH.The role of the palatine sheath and sphenopalatine artery in locating the pterygoid canal during pterygoid neurotomy [J]. Journal of Clinical Otolaryngology Head and Neck Surgery, 2020 (07).

Published
2023-09-15
Issue
Vol 12 No 3 (2023)
Section
Original Research Article

Copyright (c) 2023 Zhou Wang

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.